所属地区： --
所属机构： --
|
Published date: 5 March 2025 Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Watch this notice
Print this notice
Closing: 26 March 2025, 12pm
Contract summaryIndustryPharmacy services - 85149000 Location of contractNW1 2PB Value of contract£81,600 to £816,000 Procurement referenceCF-2881000D0O000000rwimUAA Published date5 March 2025 Closing date26 March 2025 Closing time12pm Contract start date3 November 2025 Contract end date2 November 2027 Contract typeService contract Procedure typeOpen procedure (above threshold)
What is an open procedure (above threshold)?
Any interested supplier may submit a tender in response to an opportunity notice. This procedure can be used for procurements above the relevant contract value threshold. Contract is suitable for SMEs?No Contract is suitable for VCSEs?No DescriptionThe service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service. More information
How to applyFollow the instructions given in the description or the more information section. About the buyerContact nameAaron Monaghan Address179a Tottenham Court Road Is there anything wrong with this page? |
本网站为您提供准确和及时的招投标信息，但招投标信息存在着变更的可能，请您务必在交易前向招标代理机构或招标人咨询投标详细要求，有关招标的具体要求及情况以招标代理机构或招标人的解释为准。
如果您对这篇招标信息有任何补充或修改建议，请告知我们。
猜你喜欢